Intrinsic Value of S&P & Nasdaq Contact Us

Silo Pharma, Inc. SILO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
21/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — SILO

Silo Pharma, Inc. (SILO) has a market capitalization of $3.2M and trades at $0.40. The 52-week range is 0.221-1.19.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.8, Earnings Per Share (EPS) of $-0.50, annual revenue of $72.1K.

The stock has a beta of 0.59, operates in the Healthcare sector.

Trading Data
Current Price$0.40
52-Week Range0.221-1.19
Volume514.83K
Avg Volume (30D)4.14M
Market Cap$3.2M
Beta (1Y)0.59
Company
IPO Date2021-01-08
Employees3
CEOEric Weisblum
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS82711P2011
CUSIP82711P102
Income (Latest Year)
Revenue$72.1K
Gross Profit$-813.96K
EBITDA$-4.28M
Operating Income$-4.28M
Net Income$-4.23M
EPS$-0.50
EPS Diluted$-0.50
Shares Outstanding$8.38M
Balance Sheet (Latest Year)
Total Assets$7.61M
Current Assets$7.39M
Cash & ST Investments$6.86M
Total Liabilities$1.3M
Net Debt$-4.75M
Total Equity$6.31M
Valuation Ratios
P/E Ratio-0.8
P/S Ratio44.44
P/B Ratio0.51
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message